Albendazole Vs Mebendazole In Treating Enterobiasis: A Comparative Review
Published on: November 5, 2025
Albendazole Vs Mebendazole In Treating Enterobiasis: A Comparative Review
Article author photo

Lalini Deva

Doctor of Pharmacy (Pharm.D), Seven Hills College of Pharmacy, Tirupati, India

Article reviewer photo

Sanojha Rajhbavan

Dr (MUDr.), Charles University Second Faculty of Medicine

Both albendazole and mebendazole are highly effective first-line treatments for enterobiasis, with healing rates over 90% when taken as a single dose and then again two weeks later to kill newly hatched worms.1 Some tests show that albendazole may work comparatively better and more often, while mebendazole is still a cheap and easy-to-take choice, often used by both adults and kids.2

Introduction

Enterobiasis is one of the most common worm infections in the gut around the world. It reaches many, many people, mostly children aged between 5 and 10 years old.3 The tiny worm Enterobius vermicularis causes this. It has a simple life path and often spreads when tiny pieces of faecal matter make their way into someone's mouth. Though not viewed as a harmful infection, enterobiasis can still affect you badly. It can lead to itchiness, not being able to sleep well, and sometimes changes how children behavet⁾.4 So, treatment aims to ease these signs and keep them from spreading in homes and places with many people.

Understanding enterobiasis

Enterobiasis spreads when a person swallows infective eggs. This can happen through dirty hands, food, or contact with contaminated surfaces. The eggs open in the small bowel, and the young grow into adults in the large bowel. At night, female worms move to the area around the anus to lay eggs, and this causes the main sign: nocturnal perianal pruritus. Since scratching moves eggs to the hands and nails, it's easy to get infected again, and eggs can quickly spread to others at home. This leads to many people getting sick at schools and daycare centres.5

If not treated, enterobiasis can last for months because of self-infection. Problems are rare, but they might include vulvovaginitis in females, extra infection from scratching, or even involve the appendix in some cases.6 Diagnosis is most commonly confirmed by the cellophane tape test, performed early in the morning before bathing, which allows visualisation of eggs under the microscope.

Albendazole and mebendazole: pharmacological overview

Albendazole and mebendazole are two key drugs used to treat worms in the gut. They are often the top choice for handling enterobiasis. Both are part of the benzimidazole group of worm-killing drugs and work in the same way. They work by selectively binding to β-tubulin in the worms, stopping the build-up of microtubules. This interrupts the tiny tubes inside the cells, blocking how components move inside the cells, cutting off the energy supply, and using up energy stores. This leads to the worms not being able to move, and then they die. This process is effective because it mostly harms the worm cells more than human cells, making these drugs quite safe to use.

Albendazole is a type of chemical with a wide range of power against gut worms (Enterobius vermicularis, Ascaris lumbricoides, Trichuris trichiura), and also worms in other body parts, such as Echinococcus granulosus (hydatid cysts) and Taenia solium (neurocysticercosis). It even works on some tiny bugs, such as Giardia lamblia, in some cases. When it comes to how it moves in the body, albendazole is taken in from the gut, with around 5% actually used by the body. But, this greatly increases (five times more) when taken with a fatty meal. This fact is key since eating food with it helps it work better.

Once in the body, albendazole is quickly broken down by the liver, a process called extensive first-pass hepatic metabolism. It turns into albendazole sulfoxide, the active metabolite that fights worms inside the body. This form spreads out wide, reaching the brain's fluid (CSF), bile, and cystic fluid. That's why it is good for treating deep tissue issues like neurocysticercosis and echinococcosis. Later, this metabolite changes into albendazole sulfone (inactive) and is then removed by the kidneys.

Mebendazole stands out due to its minimal systemic absorption. Only about 2-10% of the dose taken is taken up by the body. This small intake can be good because it lets a lot of the drug remain in the gut, where many worms live. This helps the drug work well there but results in fewer side effects in the rest of the body.9 So, mebendazole is a top pick for dealing with localised intestinal infections such as enterobiasis, mainly when they are not too severe.

Moreover, the weak spread of mebendazole in the body makes it a good choice for pediatric patients or for people who need less of it going through their system, like those with liver-related illness or pregnant women late in their terms (after weighing the pros and cons). Yet, this same trait lowers its power to fight whole-body worm issues, such as hydatid sickness or neurocysticercosis, where albendazole is seen as better.

Comparative clinical efficacy

Many randomised clinical trials and many systematic reviews have looked deeply into how well albendazole and mebendazole work to treat enterobiasis. In all, both drugs show very high cure rates, often more than 90% with just one oral dose, if the second dose is repeated after two weeks to kill worms from leftover eggs. This second round is key because neither drug hits unhatched eggs; without the second dose, the number of cases may go up a lot in a month.10

A study done by Albonico et al. looked at information from many tests. They found out that albendazole had a bit higher cure rate for parasites (94–97%) than mebendazole (92–95%). Even if this small change was not key in most tests, it could still matter in places with lots of worms, many sicknesses, or not good clean habits.11 Albendazole’s good body absorption and change to its working form, albendazole sulfoxide, might be why it does a bit better when worms move out of the gut, like in hard cases of the sickness.

Both drugs are well-liked by the World Health Organisation (WHO) for mass deworming campaigns, mainly in areas with a lot of soil-transmitted helminths. These efforts try to cut down on sickness, boost school work, and make children grow better.12 Mebendazole is often the top pick in public health plans, mostly because it costs less, keeps well, and you can find it easily. This makes it good for giving to a lot of people. Yet, Albendazole is now more commonly used in big deworming plans that also go after other worms like hookworm and Ascaris lumbricoides, since it works against a wider range of bugs.

Also, studies show that adding educational and hygiene interventions to treatment helps lower the risk of getting reinfected and boosts how well the whole program works. Giving drugs to everyone (MDA) every 6 to 12 months can really cut down how common enterobiasis is in schools and places where people live, over time.¹² This points out that drug therapy, even though it works very well, must be used along with ways to stop the sickness before it starts for long-term control.

Dosing and administration

The usual dose for albendazole to deal with enterobiasis is 400 mg by mouth, taken once. You should take it again after 14 days.13 For mebendazole, it's 100 mg, also taken by mouth, and you take it again after 14 days as well. You can take both drugs with or without food. Yet, albendazole works better if you take it with a fatty meal.

For kids under two, the WHO says to treat only if the infection is bad or shows clear signs. Mebendazole is often the better choice for them because it goes less into the body.12

Safety and adverse effects

Both albendazole and mebendazole are mostly well-received when taken as a one-time dose. The most commonly seen side effects are light belly pain, feeling sick, loose stools, and short-lived headaches.14 Albendazole may also lead to a short rise in liver enzymes and should be used with care by people with past liver issues.

Very bad side effects, like bone marrow loss or pancytopenia, are super rare. They are mostly seen with long, strong doses used for deep-set worm issues, not for the brief care of enterobiasis⁾.15

Both drugs are classified as pregnancy category C and are contraindicated in the first trimester unless the potential benefit outweighs the risk. In the second and third trimesters, WHO recommends their use in areas with high worm burden to reduce maternal anaemia and improve birth outcomes⁾.12

Resistance, reinfection, and prevention

True drug resistance in Enterobius vermicularis is still not common, but reinfection happens a lot. Since eggs are sticky and can stay on clothes, bed sheets, and surfaces for 2–3 weeks, it is key that patients and their homes stay very clean.

 Steps they should take include:

  • Washing hands before eating
  • Keeping fingernails short
  • Taking a bath every morning
  • Cleaning bed sheets and underwear with hot water
  • Vacuuming floors and furniture16

It's a good idea for all family members to get treated, even if they don't show symptoms, to stop the spread of the bugs. In places like schools or homes for groups, giving treatment to everyone and cleaning the place well greatly cuts down on the bugs being around⁾.17

Practical considerations in drug selection

From a real-world view, the pick between albendazole and mebendazole hangs on things like whether you can get it, how much it costs, how old the patient is, and other worm issues they have.

Albendazole is often used in places with many kinds of worm problems because it works on more types, such as hookworm, Ascaris lumbricoides, and some tapeworms.8

Mebendazole is still picked a lot where the price is key, and since it doesn't go much into the body, it's good for young kids.

Summary

Albendazole and mebendazole remain the mainstay treatments for enterobiasis, with cure rates exceeding 90% when used correctly. Albendazole shows slightly higher efficacy and broader coverage, while mebendazole offers affordability and excellent local tolerability. The success of therapy depends not only on medication but also on strict hygiene measures and treatment of all close contacts to prevent reinfection.

FAQs

Which is better for pinworm infection — albendazole or mebendazole?

Both albendazole and mebendazole are highly effective, with cure rates above 90% when given as a single dose and repeated after two weeks.¹⁰ Albendazole may have slightly higher efficacy in heavy infections due to its better systemic absorption, but mebendazole remains a reliable and cost-effective option.¹¹

Can a single dose of medicine cure a pinworm infection

A single dose can kill most adult worms, but it does not kill eggs. That is why a second dose is recommended after 14 days to prevent reinfection from newly hatched larvae.¹⁰

Can children take albendazole or mebendazole?

Yes. Both drugs are approved for children over 1 year of age.¹² For children under 2 years, WHO recommends treatment only if the infection is confirmed and symptomatic. Mebendazole may be preferred in this age group because of its minimal systemic absorption.

Are these medicines safe during pregnancy?

Albendazole and mebendazole are considered pregnancy category C and should be avoided in the first trimester unless the benefit outweighs the risk. In the second and third trimesters, the WHO allows their use in areas with a high worm burden to reduce maternal anaemia and improve pregnancy outcomes.¹²

What side effects should I expect?

Both medications are generally well-tolerated. Mild abdominal pain, nausea, diarrhoea, or headache may occur but usually resolve on their own.¹⁴ Serious side effects are rare and mainly associated with long-term high-dose therapy for systemic infections.¹⁵

Can pinworms come back after treatment?

Yes. Reinfection is very common because pinworm eggs can survive for weeks on bedding, clothing, and surfaces. Good hygiene, regular washing of hands and clothes, and simultaneous treatment of all family members can reduce the risk of recurrence.¹⁶

References 

  1. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. Int J Parasitol. 2008;38(10):1237–56.
  2. Chiodini PL, et al. Treatment of enterobiasis: a clinical review. J Infect. 2019;78(2):95–101.
  3. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521–32.
  4. Cook GC. Enterobius vermicularis infection. Gut. 1994;35(9):1159–62.
  5. CDC. About Pinworm Infection [Internet]. Atlanta: Centers for Disease Control and Prevention; 2023 [cited 2025 Sep 5]. Available from: https://www.cdc.gov/pinworm/about/index.html
  6. Wendt S, Trawinski H, Schubert S, Rodloff AC, Mössner J, Lübbert C. The diagnosis and treatment of pinworm infection. Dtsch Arztebl Int. 2019;116(13):213–9.
  7. Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990;6(4):112–5.
  8. Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. 2003;86(2-3):141–59.
  9. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121(S1):S113–32.
  10. Ismail MM, Jayakody RL. Efficacy of single doses of mebendazole, albendazole and pyrantel pamoate in treatment of Enterobius vermicularis infection. J Trop Med Hyg. 1995;98(6):479–82.
  11. Albonico M, et al. Comparative efficacy of albendazole and mebendazole against Enterobius vermicularis. Int J Parasitol. 2016;46(9):571–80.
  12. WHO. Deworming for health and development: report of the third global meeting of the partners for parasite control. Geneva: World Health Organization; 2005.
  13. WHO Model List of Essential Medicines. 23rd List. Geneva: World Health Organization; 2023.
  14. Bekhti A, Pirotte J, Capron M. Adverse effects of benzimidazoles. Bull World Health Organ. 1980;58(5):789–95.
  15. Delatour P, Parish RC. Pharmacology and safety of albendazole. Vet Hum Toxicol. 1984;26(Suppl 1):3–11.
  16. Burkhart CN, Burkhart CG. Assessment of frequency, transmission, and genitourinary complications of Enterobius vermicularis infection. Int J Dermatol. 2005;44(10):837–40.
  17. Li HM, Zhou CH, Li ZX, Luo SS, Luo H, Tang L. Control of Enterobius vermicularis infection with mass treatment and intensive hygiene education in China. Southeast Asian J Trop Med Public Health. 2015;46(6):1038–45.
Share

Lalini Deva

Doctor of Pharmacy (Pharm.D), Seven Hills College of Pharmacy, Tirupati, India

Lalini is currently pursuing her Doctor of Pharmacy (Pharm.D) degree at Seven Hills College of Pharmacy, Tirupati. She is passionate about clinical research, pharmacology, and scientific writing. Her interests include writing evidence-based articles that bridge the gap between healthcare professionals and the public, promoting awareness of rational drug use and patient-centered care.

arrow-right